id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2004-D-0118-0005,FDA,FDA-2004-D-0118,Guidance,Supporting & Related Material,GDL-Guidance,2004-12-28T05:00:00Z,2004,12,,,2008-04-12T00:34:19Z,,0,0,090000648046fb07
FDA-2004-D-0118-0007,FDA,FDA-2004-D-0118,FDA,Notice,NAD-Notice of Availability of Data,2004-12-28T05:00:00Z,2004,12,2004-12-27T05:00:00Z,2005-12-29T04:59:59Z,2008-04-12T00:34:19Z,,0,0,090000648046fb09
FDA-2004-D-0118-0006,FDA,FDA-2004-D-0118,Guidance,Supporting & Related Material,GDL-Guidance,2004-12-28T05:00:00Z,2004,12,,,2008-04-12T00:34:19Z,,0,0,090000648046fb08
FDA-2004-D-0118-0003,FDA,FDA-2004-D-0118,Guideline,Supporting & Related Material,GDL-Guidance,2004-03-19T05:00:00Z,2004,3,,,2008-04-12T00:34:19Z,,0,0,090000648046fb05
FDA-2004-D-0118-0001,FDA,FDA-2004-D-0118,FDA,Notice,NAD-Notice of Availability of Data,2004-03-19T05:00:00Z,2004,3,2004-03-16T05:00:00Z,,2008-04-12T00:34:19Z,,0,0,090000648046faff
FDA-2004-D-0118-0002,FDA,FDA-2004-D-0118,Guideline,Supporting & Related Material,GDL-Guidance,2004-03-19T05:00:00Z,2004,3,,,2008-04-12T00:34:19Z,,0,0,090000648046fb02
FDA-2004-D-0118-0004,FDA,FDA-2004-D-0118,Guideline,Supporting & Related Material,GDL-Guidance,2004-03-19T05:00:00Z,2004,3,,,2008-04-12T00:34:19Z,,0,0,090000648046fb06